Jushi Holdings (JUSHF) Operating Leases (2021 - 2022)

Jushi Holdings (JUSHF) reported Operating Leases of $18.3 million for Q3 2022, down 7.45% quarter-over-quarter from $19.8 million in Q2 2022.

Jushi Holdings (JUSHF) Operating Leases (2021 - 2022) Analysis & Trends

Jushi Holdings (JUSHF) has 2 years of Operating Leases data on file, last reported at $18.3 million in Q3 2022.

Operating Leases for Q3 2022 came in at $18.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $18.3 million (changed N/A YoY), and the FY2021 annual result was $15.2 million, changed N/A from the prior year.
Operating Leases eased to $18.3 million in Q3 2022 per JUSHF's latest filing, from $19.8 million in the prior quarter.
Over five years, Operating Leases peaked at $19.8 million in Q2 2022 and troughed at $15.2 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Jushi Holdings	-	-	29.88 Mn

Download Data